HEYMAN RICHARD A. sold 5.2% of their position (1.23K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $32.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001584759-26-000009
Director
Since Feb 2026
-1.23K
Net shares
Net seller
$32.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.23K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−1.23K
Price / share
$26.18
Trade value
$32.20K
% of position
5.2%
2/17/2026
23.88K→22.65K
Total
Net shares
−1.23K
Net value
-$32.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/17/2026 | S · Sale | −1.23K | $26.18 | $32.20K | 5.2% | 23.88K | 22.65K |
| Total | −1.23K | -$32.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned123.67K
Common Stock
IndirectShares owned25.55K
Total
123.67K direct·25.55K indirect149.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 123.67K | Direct |
| Common Stock | 25.55K | Indirect |
| Total | 149.22K | 123.67K direct·25.55K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported